Insider · CIK 0001571819
Zane Lee
Reports to the SEC for 1 company · PALO ALTO, CA
Transactions
50
Companies
1
Filings
5
CIK
0001571819
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2016-06-24 | Anacor Pharmaceuticals, Inc.D Disposition to Issuer | −$4.39M |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsD Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsD Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-02-03 | Anacor Pharmaceuticals, Inc.A Award | — |
| 2016-02-03 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2016-02-03 | Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsA Award | — |
| 2016-01-22 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$89.1K |
| 2016-01-22 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2016-01-15 | Anacor Pharmaceuticals, Inc.S Sale | −$131K |
| 2015-12-15 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$78.3K |
| 2015-12-15 | Anacor Pharmaceuticals, Inc.S Sale | −$176K |
| 2015-12-15 | Anacor Pharmaceuticals, Inc.S Sale | −$1.07M |
| 2015-12-15 | Anacor Pharmaceuticals, Inc.S Sale | −$330K |
| 2015-12-15 | Anacor Pharmaceuticals, Inc.S Sale | −$11.5K |
| 2015-12-15 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2015-09-15 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$78.3K |
| 2015-09-15 | Anacor Pharmaceuticals, Inc.S Sale | −$208K |
| 2015-09-15 | Anacor Pharmaceuticals, Inc.S Sale | −$1.57M |
| 2015-09-15 | Anacor Pharmaceuticals, Inc.S Sale | −$183K |
| 2015-09-15 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2015-06-15 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$24.3K |
| 2015-06-15 | Anacor Pharmaceuticals, Inc.S Sale | −$300K |
| 2015-06-15 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$53K |
| 2015-06-15 | Anacor Pharmaceuticals, Inc.S Sale | −$529K |
| 2015-06-15 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2015-06-15 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2015-03-16 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$83K |
| 2015-03-16 | Anacor Pharmaceuticals, Inc.S Sale | −$445K |
| 2015-03-16 | Anacor Pharmaceuticals, Inc.S Sale | −$233K |
| 2015-03-16 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | −$83K |
| 2015-02-03 | Anacor Pharmaceuticals, Inc.A Award | — |
| 2015-02-03 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2015-02-03 | Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsA Award | — |
| 2014-12-29 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$16.3K |
| 2014-12-29 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$60.4K |
| 2014-12-29 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$19.6K |
| 2014-12-29 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | −$16.3K |
| 2014-12-29 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | −$60.4K |
| 2014-12-29 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | −$19.6K |
| 2014-12-11 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$500 |
| 2014-12-11 | Anacor Pharmaceuticals, Inc.S Sale | −$3,600 |
Recent filings
- 4Anacor Pharmaceuticals, Inc.0000950103-16-014335SEC(opens sec.gov)
- 4Anacor Pharmaceuticals, Inc.0001209191-16-096112SEC(opens sec.gov)
- 4Anacor Pharmaceuticals, Inc.0001209191-16-093488SEC(opens sec.gov)
- 4Anacor Pharmaceuticals, Inc.0001209191-16-092267SEC(opens sec.gov)
- 4Anacor Pharmaceuticals, Inc.0001209191-15-085975SEC(opens sec.gov)
Companies
Address
C/O ANACOR PHARMACEUTICALS, INC. 1020 EAST MEADOW CIRCLE
PALO ALTO, CA, 94303